Overall, these data demonstrate that blocking MMP9 using SDS3 affected not only multiple intrinsic properties of tumor cells but also affected recruitment and activation of CD8+ T cells in the lung microenvironment, which ultimately contributed to an anti-metastatic immune response (Fig 7). The gene discussed is CD8A; the disease is neoplasm.